• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重度非增殖性/增殖性糖尿病视网膜病变的发病率及危险因素:德黑兰血脂与血糖研究的十余年随访

Incidence and risk factors of severe non-proliferative/proliferative diabetic retinopathy: More than a decade follow up in the Tehran Lipids and Glucose Study.

作者信息

Sardarinia Mahsa, Asgari Samaneh, Hizomi Arani Reyhane, Eskandari Fatemeh, Azizi Fereidoun, Khalili Davood, Hadaegh Farzad

机构信息

Eye Research Center, Rasool-e-Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.

Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

J Diabetes Investig. 2022 Feb;13(2):317-327. doi: 10.1111/jdi.13647. Epub 2021 Sep 13.

DOI:10.1111/jdi.13647
PMID:34403198
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8847124/
Abstract

AIMS/INTRODUCTION: To examine the incidence rate of severe non-proliferative and proliferative diabetic retinopathy (severe-NPDR/PDR) and determine its potential risk factors.

MATERIALS AND METHODS

The study consisted of 1,169 participants (675 women) with type 2 diabetes mellitus, aged ≥20 years. A trained interviewer collected information about the history of pan-retinal photocoagulation as a result of diabetic retinopathy. Multivariable Cox proportional hazards regression models were applied.

RESULTS

We found 187 cases (126 women) of severe-NPDR/PDR during a median follow-up period of 12.7 years; the corresponding incidence rate was 13.6 per 1,000 person-years. Being overweight (hazard ratio [HR], 95% confidence interval [CI] 0.60, 0.39-0.92) and obese (HR 0.48, 95% CI 0.27-0.83) were associated with lower risk, whereas being smoker (HR 1.75, 95% CI 1.12-2.74), having fasting plasma glucose levels 7.22-10.0 mmol/L (HR 2.81, 95% CI 1.70-4.62), fasting plasma glucose ≥10 mmol/L (HR 5.87, 95% CI 3.67-9.41), taking glucose-lowering medications (HR 2.58, 95% CI 1.87-3.56), prehypertension status (HR 1.65, 95% CI 1.05-2.58) and newly diagnosed hypertension (HR 1.96, 95% CI 1.06-3.65) increased the risk of severe-NPDR/PDR. Among newly diagnosed diabetes patients, being male was associated with a 59% lower risk of severe-NPDR/PDR (HR 0.41, 95% CI 0.21-0.79). Furthermore, patients who had an intermediate level of education (6-12 years) had a higher risk of developing PDR (HR 1.86, 95% CI 1.05-3.30) compared with those who had <6 years of education.

CONCLUSIONS

Among Iranians with type 2 diabetes mellitus, 1.36% developed severe-NPDR/PDR annually. Normal bodyweight, being a smoker, out of target fasting plasma glucose level, prehypertension and newly diagnosed hypertension status were independent risk factors of severe-NPDR/PDR. Regarding the sight-threatening entity of advanced diabetic retinopathy, the multicomponent strategy to control diabetes, abstinence of smoking and tight control of blood pressure should be considered.

摘要

目的/引言:研究重度非增殖性和增殖性糖尿病视网膜病变(重度NPDR/PDR)的发病率,并确定其潜在危险因素。

材料与方法

该研究纳入了1169名年龄≥20岁的2型糖尿病患者(675名女性)。由经过培训的访员收集因糖尿病视网膜病变而进行全视网膜光凝治疗的病史信息。应用多变量Cox比例风险回归模型。

结果

在中位随访期12.7年期间,我们发现了187例重度NPDR/PDR病例(126名女性);相应的发病率为每1000人年13.6例。超重(风险比[HR],95%置信区间[CI] 0.60,0.39 - 0.92)和肥胖(HR 0.48,95% CI 0.27 - 0.83)与较低风险相关,而吸烟者(HR 1.75,95% CI 1.12 - 2.74)、空腹血糖水平为7.22 - 10.0 mmol/L(HR 2.81,95% CI 1.70 - 4.62)、空腹血糖≥10 mmol/L(HR 5.87,95% CI 3.67 - 9.41)、服用降糖药物(HR 2.58,95% CI 1.87 - 3.56)、高血压前期状态(HR 1.65,95% CI 1.05 - 2.58)和新诊断的高血压(HR 1.96,95% CI 1.06 - 3.65)会增加重度NPDR/PDR的风险。在新诊断的糖尿病患者中,男性患重度NPDR/PDR的风险降低59%(HR 0.41,95% CI 0.21 - 0.79)。此外,与受教育年限<6年的患者相比,接受中等教育水平(6 - 12年)的患者发生PDR的风险更高(HR 1.86,95% CI 1.05 - 3.30)。

结论

在伊朗2型糖尿病患者中,每年有1.36%发生重度NPDR/PDR。正常体重、吸烟、空腹血糖未达标、高血压前期和新诊断的高血压状态是重度NPDR/PDR的独立危险因素。鉴于晚期糖尿病视网膜病变对视力的威胁,应考虑采取多组分策略来控制糖尿病、戒烟和严格控制血压。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b2d/8847124/2b5bf413b676/JDI-13-317-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b2d/8847124/2b5bf413b676/JDI-13-317-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b2d/8847124/2b5bf413b676/JDI-13-317-g002.jpg

相似文献

1
Incidence and risk factors of severe non-proliferative/proliferative diabetic retinopathy: More than a decade follow up in the Tehran Lipids and Glucose Study.重度非增殖性/增殖性糖尿病视网膜病变的发病率及危险因素:德黑兰血脂与血糖研究的十余年随访
J Diabetes Investig. 2022 Feb;13(2):317-327. doi: 10.1111/jdi.13647. Epub 2021 Sep 13.
2
Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.增生性糖尿病性视网膜病变在糖尿病性视网膜病变患者中发展和进展的预测因素。
Cochrane Database Syst Rev. 2023 Feb 22;2(2):CD013775. doi: 10.1002/14651858.CD013775.pub2.
3
Impact of anti-VEGF treatment on development of proliferative diabetic retinopathy in routine clinical practice.抗血管内皮生长因子治疗对常规临床实践中增殖性糖尿病视网膜病变发展的影响。
BMC Ophthalmol. 2024 May 31;24(1):229. doi: 10.1186/s12886-024-03491-w.
4
Lipid-Lowering Medications Are Associated with Lower Risk of Retinopathy and Ophthalmic Interventions among United States Patients with Diabetes.降脂药物与美国糖尿病患者视网膜病变和眼科干预风险降低相关。
Am J Ophthalmol. 2019 Nov;207:378-384. doi: 10.1016/j.ajo.2019.05.029. Epub 2019 Jun 10.
5
Diabetic Retinopathy -Incidence And Risk Factors In A Community Setting- A Longitudinal Study.糖尿病视网膜病变——社区环境中的发病率及危险因素——一项纵向研究
Scand J Prim Health Care. 2018 Sep;36(3):237-241. doi: 10.1080/02813432.2018.1487524. Epub 2018 Jun 27.
6
Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation.全视网膜光凝及其他形式的激光治疗与药物疗法用于非增殖性糖尿病视网膜病变:系统评价与经济学评估
Health Technol Assess. 2015 Jul;19(51):v-xxviii, 1-247. doi: 10.3310/hta19510.
7
Incidence of and risk factors for proliferative retinopathy and its association with blindness among diabetes clinic attenders.糖尿病门诊患者增生性视网膜病变的发病率、危险因素及其与失明的关联
Ophthalmic Epidemiol. 2000 Dec;7(4):225-41. doi: 10.1076/opep.7.4.225.4171.
8
Anaemia and the risk of progression from non-proliferative diabetic retinopathy to vision threatening diabetic retinopathy.贫血与非增殖性糖尿病性视网膜病变进展为威胁视力的糖尿病性视网膜病变的风险。
Eye (Lond). 2020 May;34(5):934-941. doi: 10.1038/s41433-019-0617-6. Epub 2019 Oct 4.
9
The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group: Report 3: Baseline Retinopathy and Clinical Features Predict Progression of Diabetic Retinopathy.英国糖尿病视网膜病变电子病历用户组:报告3:基线视网膜病变及临床特征预测糖尿病视网膜病变的进展
Am J Ophthalmol. 2017 Aug;180:64-71. doi: 10.1016/j.ajo.2017.05.020. Epub 2017 May 29.
10
The Importance of Close Follow-Up in Patients with Early-Grade Diabetic Retinopathy: A Taiwan Population-Based Study Grading via Deep Learning Model.早期糖尿病视网膜病变患者密切随诊的重要性:基于深度学习模型分级的台湾人群研究。
Int J Environ Res Public Health. 2021 Sep 16;18(18):9768. doi: 10.3390/ijerph18189768.

引用本文的文献

1
Scoring and validation of a simple model for predicting diabetic retinopathy in patients with type 2 diabetes based on a meta-analysis approach of 21 cohorts.基于荟萃分析方法对 21 个队列的研究,建立并验证一个预测 2 型糖尿病患者糖尿病视网膜病变的简单模型。
Ann Med. 2024 Dec;56(1):2413920. doi: 10.1080/07853890.2024.2413920. Epub 2024 Oct 11.
2
Predicting vision-threatening diabetic retinopathy in patients with type 2 diabetes mellitus: Systematic review, meta-analysis, and prospective validation study.预测 2 型糖尿病患者的视力威胁性糖尿病视网膜病变:系统评价、荟萃分析和前瞻性验证研究。
J Glob Health. 2024 Oct 11;14:04192. doi: 10.7189/jogh.14.04192.
3

本文引用的文献

1
Trends in Diabetes Treatment and Control in U.S. Adults, 1999-2018.美国成年人糖尿病治疗和控制的趋势,1999-2018 年。
N Engl J Med. 2021 Jun 10;384(23):2219-2228. doi: 10.1056/NEJMsa2032271.
2
High Incidence of Chronic Kidney Disease among Iranian Diabetic Adults: Using CKD-EPI and MDRD Equations for Estimated Glomerular Filtration Rate.伊朗成年糖尿病患者慢性肾脏病发病率高:应用 CKD-EPI 和 MDRD 方程估算肾小球滤过率。
Diabetes Metab J. 2021 Sep;45(5):684-697. doi: 10.4093/dmj.2020.0109. Epub 2021 Mar 16.
3
Thirty-Year Trends in Complications in U.S. Adults With Newly Diagnosed Type 2 Diabetes.
Efficacy comparison of multipoint and single point scanning panretinal laser photocoagulation in non-proliferative diabetic retinopathy treatment.
多点与单点扫描全视网膜激光光凝治疗非增殖性糖尿病视网膜病变的疗效比较
World J Diabetes. 2024 Aug 15;15(8):1734-1741. doi: 10.4239/wjd.v15.i8.1734.
4
Microglia in retinal angiogenesis and diabetic retinopathy.视网膜血管生成和糖尿病视网膜病变中的小胶质细胞。
Angiogenesis. 2024 Aug;27(3):311-331. doi: 10.1007/s10456-024-09911-1. Epub 2024 Apr 2.
5
Association between estimated glomerular filtration rate slope and cardiovascular disease among individuals with and without diabetes: a prospective cohort study.估算肾小球滤过率斜率与糖尿病患者和非糖尿病患者心血管疾病的关系:一项前瞻性队列研究。
Cardiovasc Diabetol. 2023 Oct 4;22(1):270. doi: 10.1186/s12933-023-02008-x.
6
Experimental Models to Study Epithelial-Mesenchymal Transition in Proliferative Vitreoretinopathy.研究增生性玻璃体视网膜病变中上皮-间充质转化的实验模型。
Int J Mol Sci. 2023 Feb 24;24(5):4509. doi: 10.3390/ijms24054509.
7
Recent updates in factors associated with incidence and screening of diabetic eye disease.糖尿病眼病发病率及筛查相关因素的最新进展
J Diabetes Investig. 2023 Jun;14(6):744-745. doi: 10.1111/jdi.13991. Epub 2023 Feb 10.
8
Prevalence of and Factors Associated with Diabetic Retinopathy in Patients with Diabetes Mellitus at Siriraj Hospital - Thailand's Largest National Tertiary Referral Center.泰国最大的国立三级转诊中心诗里拉吉医院糖尿病患者糖尿病视网膜病变的患病率及相关因素
Diabetes Metab Syndr Obes. 2021 Dec 29;14:4945-4957. doi: 10.2147/DMSO.S346719. eCollection 2021.
美国新诊断 2 型糖尿病成年人并发症 30 年趋势。
Diabetes Care. 2021 Mar;44(3):699-706. doi: 10.2337/dc20-2304. Epub 2021 Jan 8.
4
11. Microvascular Complications and Foot Care: .11. 微血管并发症和足部护理: 。
Diabetes Care. 2021 Jan;44(Suppl 1):S151-S167. doi: 10.2337/dc21-S011.
5
6. Glycemic Targets: .6. 血糖目标: 。
Diabetes Care. 2020 Jan;43(Suppl 1):S66-S76. doi: 10.2337/dc20-S006.
6
Is central obesity associated with diabetic retinopathy in Chinese individuals? An exploratory study.中心性肥胖与中国人群糖尿病视网膜病变有关联吗?一项探索性研究。
J Int Med Res. 2019 Nov;47(11):5601-5612. doi: 10.1177/0300060519874909. Epub 2019 Sep 23.
7
Trends in incidence of total or type 2 diabetes: systematic review.糖尿病发病率的趋势:系统综述。
BMJ. 2019 Sep 11;366:l5003. doi: 10.1136/bmj.l5003.
8
Metabolic health in the Middle East and north Africa.中东和北非的代谢健康。
Lancet Diabetes Endocrinol. 2019 Nov;7(11):866-879. doi: 10.1016/S2213-8587(19)30179-2. Epub 2019 Aug 14.
9
Risk factors for prevalent diabetic retinopathy and proliferative diabetic retinopathy in type 1 diabetes.1 型糖尿病患者中常见糖尿病性视网膜病变和增生性糖尿病性视网膜病变的危险因素。
Endocrine. 2019 Nov;66(2):201-209. doi: 10.1007/s12020-019-02047-z. Epub 2019 Aug 12.
10
[Clinical features of diabetic retinopathy in pregnancy].[妊娠期糖尿病视网膜病变的临床特征]
Vestn Oftalmol. 2019;135(3):55-66. doi: 10.17116/oftalma201913503155.